CON/217/RX4 = Supply of COBALT Drug Trial Requirements
Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust are seeking expressions of interest from capable bidders for the following opportunity: COmBining memantine And cholinesterase inhibitors in Lewy body dementia treatment Trial (COBALT) Introduction Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust (CNTW) and The University of Melbourne (UoM), Australia have successfully bid for funding to run 2 National, multi-site, placebo controlled clinical trial assessing if adjunctive Memantine use in patien...
Buyer
Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust
Value
Not provided
Published
9 Jul 2021
Closes
10 Aug 2021
Procurement details
Source
Find a Tender
Region
North East (England)
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 CON/217/RX4 = Supply of COBALT Drug Trial Requirements
Value not provided
See II.1.4. Short description and Tender documents for further detail.
Delivery: North East (England)
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.